1. Home
  2. Faculty

Diana Jalal, MD

Professor of Internal Medicine-Nephrology

Current Positions

  • Professor of Internal Medicine-Nephrology
  • Director for Clinical Research, Renal Division
  • Associate Director, CADRE Iowa City VA

Education

  • MBBS, The University of Jordan, Amman, Jordan
  • Resident, Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa
  • Fellow, Nephrology, Baylor College of Medicine, Houston, Texas
  • Research Fellow, University of Texas, Houston, Texas

Center, Program and Institute Affiliations

Selected Publications

  • Griffin, B. R., Wu, C., O'Horo, J. C., Faubel, S., Jalal, D. & Kashani, K. (2021). The Association of Platelet Decrease Following Continuous Renal Replacement Therapy Initiation and Increased Rates of Secondary Infections. Critical care medicine 49 (2) e130-e139. DOI: 10.1097/CCM.0000000000004763.
  • Jalal, D. I. & Chertow, G. M. (2021). Urate Lowering With Combination Therapy in CKD: Reason for Optimism or Einstein's Definition of Insanity?. American Journal of Kidney Diseases. DOI: 10.1053/j.ajkd.2020.11.007.
  • Kruse, N. T., Buzkova, P., Barzilay, J. I., Valderrabano, R. J., Robbins, J. A., Fink, H. A. & Jalal, D. I. (2020). Association of skeletal muscle mass, kidney disease and mortality in older men and women: the cardiovascular health study. Aging 12 (21) 21023-21036. DOI: 10.18632/aging.202135.
  • Kruse, N. T., You, Z., Moreau, K., Kendrick, J. & Jalal, D. (2020). Sex differences in endothelial function in chronic kidney disease. American Journal of Physiology - Renal Physiology 319 (1) F33-F40. DOI: 10.1152/ajprenal.00156.2020.
  • Griffin, B. R., You, Z., Noureddine, L., Gitomer, B., Perrenoud, L., Wang, W., Chonchol, M. & Jalal, D. (2020). KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results. American Journal of Nephrology 51 (6) 473-479. DOI: 10.1159/000508051.
  • Batchelor, E. K., Kapitsinou, P., Pergola, P. E., Kovesdy, C. P. & Jalal, D. I. (In Press). Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis and Treatment. J Am Soc Nephrol 31 (3) 456-468. DOI: 10.1681/ASN.2019020213. PMID: 32041774.
  • Stites, E., Renner, B., Laskowski, J., Le Quintrec, M., You, Z., Freed, B., Cooper, J., Jalal, D. & Thurman, J. M. (2020). Complement fragments are biomarkers of antibody-mediated endothelial injury. Molecular Immunology 118 142-152. DOI: 10.1016/j.molimm.2019.12.011.
  • Perrenoud, L., Kruse, N., Andrews, E., You, Z., Chonchol, M., Wu, C., Ten Eyck, P., Zepeda-Orozco, E. & Jalal, D. (In Press). Uric Acid Lowering and Biomarkers of Kidney Damage in CKD Stage 3: a Post-hoc Analysis of a Randomized Clinical Trial. Kidney Medicine.
  • Griffin, B. R., Bronsert, M., Reece, T. B., Pal, J. D., Cleveland, J. C., Fullerton, D. A., Gist, K. M., Jovanovich, A., Jalal, D., Faubel, S. & Aftab, M. (2019). Thrombocytopenia After Cardiopulmonary Bypass is Associated with Increased Morbidity and Mortality. The Annals of thoracic surgery. DOI: 10.1016/j.athoracsur.2019.10.039. PMID: 31816284.
  • Griffin, B. R., Thomson, A., Yoder, M., Francis, I., Ambruso, S., Bregman, A., Feller, M., Johnson-Bortolotto, S., King, C., Bonnes, D., Dufficy, L., Wu, C., Bansal, A., Tad-y, D., Faubel, S. & Jalal, D. (2019). Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative. American Journal of Kidney Diseases 74 (6) 727-735. DOI: 10.1053/j.ajkd.2019.06.013.